- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02314741
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility (POEM)
Peroral Endoscopic Myotomy (POEM) for Esophageal Motility in Patients With a Clinical Diagnosis of Achalasia
The investigators wish to monitor the adoption of a new, incisionless approach to performing a Heller myotomy for the surgical treatment of achalasia. The method, the Peroral Endoscopic Myotomy (POEM), will provide less-invasive treatment for esophageal achalasia, ideally providing similar if not better outcomes (safety and efficacy) as the Heller myotomy. The investigators hope to enroll 10 patients with a clinical diagnosis of achalasia who meet inclusion criteria.
The POEM procedure has been done in many hospitals without any research associated with it. Dr. Ginsberg, Dr. Chandrasekhara and Dr. Kochman will perform the procedures after being trained. Dr. Ginsberg has personally witnessed the performance of 10 POEM procedures and has performed in a swine model. The PI is credentialed to initiate POEM at HUP with the first case to be proctored by an experienced operator. The PI will then proctor the other adopters. The investigators would like to evaluate the safety of it and the effectiveness of it. The investigators will use their symptom scores and radiology tests pre- and post-POEM to evaluate effectiveness.
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age > or = to 18 years of age
- Clinical diagnosis of achalasia
- A candidate for Heller myotomy
- Esophageal manometry and barium esophogram with findings supportive of achalasia diagnosis
- Women of childbearing potential: negative urine pregnancy test
- Able to undergo general anesthesia
- Willing and able to give informed consent
Exclusion Criteria:
- < 18 years of age
- Pregnancy
- Previous mediastinal or esophageal surgery
- Contraindications for esophagogastroduodenoscopy
- Presence of malignancy
- Coagulopathy (INR 1.5)
- Thrombocytopenia (platelet count < 100K/microliter)
- ASA Score > Class II
- History of mental illness
- Any medical conditions as determined by the PI to be a contraindication to the procedure
- Unable to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: POEM Treatment Arm
Patients treated with the POEM (per-oral endoscopic myotomy) procedure.
|
The procedure is performed under anesthesia.The procedure involves endoscopic electrosurgical dissection with an Olympus triangular tip knife.The myotomy is usually ~6cm long & averages 8-10cm.
After the myotomy is performed the scope is withdrawn & inserted into the lumen to inspect the mucosa, ensure mucosal integrity & confirm easy passage of the endoscope through the LES consistent with an adequate myotomy.
The mucosal entry site is usually 2-3cm long, & is closed with 5-10 endoscopic clips.
Patients are hospitalized after procedure for observation.The patient is given IV-nutrition until post-operative day 1.
An esophagram is obtained.
If no loss of mucosal integrity or leak is noted, a liquid diet is started, which is continued for several days before initiating a solid diet.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gather Standardized Data on Patients with Achalasia Who Have Been Treated with the POEM Procedure
Time Frame: About 12 months
|
The primary aim of this study is to assess safety and efficacy in the adoption of the POEM procedure compared to the typical Heller Myotomy used for the treatment of achalasia using standardized methods, including esophageal manometry, pre- and post- procedure barium swallow studies, as well as standardized measures of dysphagia symptoms due to achalasia (the Eckart score), and patient's medical records and self-reported symptoms.
|
About 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pre-Procedure versus Post-Procedure Barium Swallow Results in POEM Patients
Time Frame: About 6 Months
|
Assess POEM procedure's efficacy as defined by improvement of barium swallow study and dysphagia symptoms associated with achalasia.
Barium swallow study will compare pre- and post-operative esophageal emptying.
|
About 6 Months
|
|
Pre-Procedure Versus Post-Procedure Eckart Score Results in POEM Patients
Time Frame: About 6 Months
|
Assess POEM procedure's efficacy as defined by improvement of dysphagia symptoms associated with achalasia.
Dysphagia improvement will be assessed using a pre- and post-surgical standardized dysphagia scoring system known as an Eckart Score.
|
About 6 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Vinay Chandrasekhara, MD, University of Pennsylvania
- Principal Investigator: Gregory G Ginsberg, MD, University of Pennsylvania
- Principal Investigator: Gary W Falk, MD, MS, University of Pennsylvania
- Principal Investigator: Michael Kochman, MD, University of Pennsylvania
- Principal Investigator: David C Metz, MD, University of Pennsylvania
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 819130
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Achalasia
-
Federico II UniversityRecruitingAchalasia | Indocyanine Green | Indocyanine Green (ICG) | Achalasia, EsophagealItaly
-
Cairo UniversityRecruitingAchalasia | Achalasia CardiaEgypt
-
Mayo ClinicTerminatedAchalasia | Esophageal Achalasia | Achalasia, EsophagealUnited States
-
Federico II UniversityCompleted
-
Asian Institute of Gastroenterology, IndiaCompleted
-
The First Affiliated Hospital of Zhengzhou UniversityRecruitingDysphagia | Cricopharyngeal AchalasiaChina
-
Baylor College of MedicineRecruitingEsophageal Motility Disorders | AchalasiaUnited States
-
Peking Union Medical College HospitalCompleted
-
Zeng ChanghaoRecruitingCricopharyngeal AchalasiaTaiwan
-
Northwestern UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType I Achalasia | Type II Achalasia | EGJ Outflow Obstruction Without Spastic/Hypercontractile FeaturesUnited States
Clinical Trials on POEM Procedure
-
McMaster UniversityCompleted
-
AdventHealthMayo Clinic; University of South FloridaCompleted
-
Shanghai Zhongshan HospitalUnknownEsophageal AchalasiaChina
-
University of California, IrvineCedars-Sinai Medical Center; University of Ottawa; Hoag Memorial Hospital Presbyterian and other collaboratorsNot yet recruitingAchalasia, Esophageal | GERD (Gastroesophageal Reflux Disease)United States
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Shanghai Zhongshan HospitalUnknown
-
Karolinska InstitutetActive, not recruiting
-
Weill Medical College of Cornell UniversityUnknownAchalasiaUnited States
-
Shanghai Zhongshan HospitalUnknown
-
Asian Institute of Gastroenterology, IndiaActive, not recruitingBiological Optimization Versus Standard Care in Post-POEM Achalasia Patients (BIO-POEM) (BIO-POEM 1)Achalasia Cardia | GERD (Gastroesophageal Reflux Disease)India